ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

DCPC Board Approves Concepts Of Six New RFAs Totaling $9.3 Million A Year

May 11, 1984

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994